secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001140361-24-031811
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics prices $11.5M public offering of common stock and warrants
------------------------------------------------------------------------------

- Gross proceeds ~$11.5M; net proceeds ~$10.9M after discounts and expenses.
- Offering consists of 500K shares and 1.8M pre-funded warrants, each with common warrants exercisable at $5.00 for 5 years.
- Combined price: $5.00 per share+common warrant; $4.99 per pre-funded warrant+common warrant.
- Expected to close July 1, 2024; proceeds to advance development pipeline and for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000114036124031811/0001140361-24-031811-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000114036124031811/ny20031755x4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-031811

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer